Cost of cancer care: Issues and implications
Cost of cancer care: Issues and implications
复制标题
DOI：
10.1200/jco.2006.09.6081
复制
发表时间：
2007-01-10
影响因子：
45.3
通讯作者：
Schulman, Kevin A.
中科院分区：
文献类型：
--
作者：
Meropol, Neal J.;Schulman, Kevin A.
在大多数临床医学领域，医疗技术的成本越来越高。肿瘤学也未能幸免于与成本相关的问题，部分原因是巨大的科学进步带来了新的诊断，治疗和患者随访工具。医疗保健（特别是癌症护理）费用的增加提出了与其对我们的经济和社会公民的影响有关的复杂问题。本文回顾了宏观经济原则和管理医疗支出的个人行为，并探讨了成本如何不成比例地影响不同的人群。我们的总体目标是对影响肿瘤学临床实践的卫生政策问题进行辩论。
Medical technology is increasingly costly in most fields of clinical medicine. Oncology has not been spared from issues related to cost, in part resulting from the tremendous scientific progress that has lead to new tools for diagnosis, treatment, and follow-up of our patients. The increasing cost of health care in general ( and cancer care in particular) raises complex questions related to its effects on our economy and the citizens of our society. This article reviews the macroeconomic principles and individual behaviors that govern medical spending, and examines how cost disproportionately affects various populations. Our overall goal is to frame debate about health policy concerns that influence the clinical practice of oncology.